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Summary 
Natural killer (NK) cells play an important role in immune response by producing interferon ~/ 
(IFN-~/) as well as exhibiting cytotoxic function.  IFN-~/produced by NK cells has been sug- 
gested to be involved in differentiation  of T  helper cells.  On  the  other hand,  the  NKR-P1 
molecule was recently identified as one of the important NK cell receptors, and it recognizes 
certain kinds of oligosaccharides on target cells  and triggers NK cells  for cytotoxicity. In the 
present study, we found that NK cells produce great amounts of IFN-~/upon cross-linking of 
the NKR-P1  molecule.  In contrast,  stimulation of NK cells  with IL-2 induced  proliferation 
without producing IFN-% Similar to NK cells,  NKI.1 + T  cells  also  produced  IFN-~/ upon 
NKR-P1  cross-linking.  NKI.1 §  T  cells  produced  IFN-~/but not interleukin  4  (IL-4) upon 
NKtk-P1  cross-linking,  whereas  they  secreted  both  IFN-~/  and  IL-4  upon  T  cell  receptor 
cross-linking. These results indicate that NKR-P1 is a receptor molecule on NK and NKI.1 + 
T  cells that induces not only cytotoxicity but also IFN-~/production. Our findings provide a 
new pathway for IFN-~/production by NK and NKI.1 § T  cells through NKR-P1 molecules; 
it may be essential for immune regulation. 
N 
'K cells exhibit cytotoxicity against certain tumor cells 
and  virus-infected  cells  without  prior  sensitization 
and  seem  to  represent  unique  lymphocytes  that  are  in- 
volved in host defense (1-3). NK cells do not express TCR 
and  exhibit  non-MHC-restricted  cytotoxicity, unlike  cy- 
totoxic T  cells.  Susceptibility to NK cell cytotoxicity is in 
part correlated with the expression of sugar chain or MHC 
class I antigen on target cells.  From these observations, NK 
cells  were  thought  to  recognize  target  cells  by using  un- 
known molecules different from TCR  and BCR.  The rat 
NKR-P1  molecule was the first receptor protein that was 
thought  to  be involved in  target  cell  recognition by NK 
cells  (4,  5).  The NKtk-P1  molecule contains  a lectin-like 
domain, and cross-linking of NKtk-P1  induced cytotoxic- 
ity in NK cells (4, 6). NK1.1 antigen, which has been used 
as a specific marker for mouse NK cells, has been shown to 
be one of the mouse NKP,-P1 molecules and to induce cy- 
totoxicity in NK cells upon cross-linking with anti-NKl.1 
mAb  (6-8).  Recently,  Bezouska et al.  (9)  clearly demon- 
strated by using a soluble form of NKR-P1 molecule and a 
series of oligosaccharides that NKR-P1  is a key molecule 
that  induces  cytotoxicity of NK cells  by recognizing  oli- 
gosaccharides expressed on target cells.  This finding estab- 
lished that NKR-P1  is a receptor protein of NK cells that 
recognizes target cells and induces cytotoxicity. 
On the other hand, NK cells are known to secrete a high 
level of IFN-% and the produced IFN-~ is thought to be 
important for the immune response against pathogens (10- 
12).  Recently, IL-12 produced by macrophages was found 
to be a most potent inducer of IFN-~ from NK cells  (13, 
14),  indicating that IL-12 plays a major role in NK cell ac- 
tivation.  However,  analysis  of IFN-',/  receptor-deficient 
mice showed that IFN-~/ was required for IL-12 produc- 
tion  upon infection with Mycobacterium  bovis bacillus  Cal- 
mette-Gu~rin  (BCG)  or LPS  stimulation  (15).  Therefore, 
cells  producing IFN-~ at the initial phase of immune de- 
fense are particularly important for immune response. 
Recently, we and others have found a novel T  cell pop- 
ulation  expressing  NKR-P1  (NKI.1)  molecule  and 
TCRo~/[3  in  CD4 §  T  cells  (16-20)  and  CD4-  CD8-  T 
cells (19-24). NK1.1 + T  cells express an invariant TCR V~ 
and V~3 repertoire and seem to recognize the [~2-microglo- 
bulin-associated CD1  molecule (25,  26).  Furthermore, we 
(17) and others (27) have found that NKI.1 + T  cells are the 
major  population  that  produces  high  amounts  of IFN-'y 
and IL-4 upon primary stimulation through TCR. Therefore, 
NKI.1 +  T  cells  are  considered  to  be  a  regulatory T  cell 
population that is involved in the determination ofT helper 
cell differentiation  (17,  27-30).  However, the function  of 
the NKR-P1 molecule on the activation ofNK1.1 + T  cells 
remains unclear. 
In the present study, we found that cross-linking of one 
of the mouse NKR-P1 molecules, NKI.1 Ag, with immo- 
bilized anti-NKl.1  mAb induced  IFN-~/production from 
NK cells and NKI.1 § T  cells in the absence of IL-12. Fur- 
thermore,  NKI.1 +  T  cells  did  not  produce  IL-4  upon 
NKR-P1  cross-linking,  unlike  upon  TCR  cross-linking. 
These findings suggest that oligosaccharide recognition by 
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is involved in the  regulation of IFN-~/ production in im- 
mune response. 
Materials  and  Methods 
Mice.  C57BL/6 mice were obtained from the Shizuoka Lab- 
oratory Animal Corporation (Hamamatsu,  Shizuoka Prefecture, 
Japan). 
Cellpreparation.  NK cells and NKI.1 + T  cells were purified 
as previously described (19, 31).  In brief, NK cells were purified 
from  spleen  of 6-8-w-old  C57BL/6  mice.  Splenocytes  were 
mixed with anti-CD4 mAb (GK1.5) and anti-CD8 mAb (53.6.7) 
and incubated with magnetic beads  (Advanced Magnetics, Inc., 
Cambridge, MA) coupled with goat anti-mouse IgG Ab and goat 
anti-rat IgG Ab (Organon Teknika Co., West Chester,  PA) to 
remove surface  Ig (slg) + B  cells and CD4 + and CD8 + T  cells. 
The residual cells were then incubated with PE-anti-NKl.1 mAb 
and FITC-anti-CD3 mAb (PharMingen,  San Diego, CA).  The 
stained cells were sorted into NKI.1 + CD3-  cells by FACStar- 
Plus  |  (Becton Dickinson, Mountain View, CA). NKI.1 + T  cells 
were prepared from thymus. Thymocytes were treated with anti- 
HSA mAb (J11d)  followed by complement treatment.  The  re- 
sultant  cells  were  incubated  with  anti-CD8  and  anti-MEL-14 
mAbs. Thereafter, CD8 + MEL-14 + cells were removed by use of 
magnetic beads coupled with goat anti-rat IgG Ab. The residual 
cells were then incubated with PE-anti-NKl.1 mAb and FITC- 
anti-CD3 mAb. The stained cells were sorted into NKI.1 + CD3 + 
cells. The purity of the sorted cells was always more than 99%. 
Cell Culture and Stimulation.  Basically, purified cells were cul- 
tured in RPMI  1640  supplemented with  10%  FCS, kanamycin 
(100  p,g/m.l),  and 5  X  10 -s M  2-ME. NK cells were expanded 
by culturing freshly purified NK cells for 3 d in the presence of 
1,000  U/nil human recombinant IL-2 (kindly provided by Dr. J. 
Hamuro, Ajinomoto Co., Inc., Kawasaki, Japan). 10  s NK cells and 
NK1.1 + T cells were stimulated with immobilized anti-NK1.1 or 
anti-TCR-[3  mAbs,  or with  recombinant mouse  IL-12  (Phar- 
mingen, 500 pg/ml IL-12 induced almost maximum production 
of IFN-"/) for certain periods. Anti-NKl.1 mAb or and-TCR-[3 
mAb  was  immobilized on  96-well flat-bottomed culture  plate 
(Costar, Cambridge, MA) by incubating for 2 h at 37~  at certain 
concentrations in PBS. In some experiments, NK cells were stim- 
ulated in the presence ofanti-IL-12 mAb (clone C17.8, generous 
gift of Dr. G. Trinchieri, Wistar Institute, Philadelphia, PA). Af- 
ter the cultures,  [3H]thymidine incorporation and concentration 
oflFN-y in the culture supernatant were determined. All data are 
presented as mean +  SD from triplicate cultures. 
Measurement oflFN-y and 1i.-4.  IFN-~/ and  IL-4 were mea- 
sured by ELISA by standard protocol. The mAbs used to capture 
IL-4 and IFN-y were anti-IL-4 (BVD4-1D11)  and IFN-',/ (P,4- 
6A2) mAbs, respectively. The mAbs used to detect captured IL-4 
and IFN-'y were biotinylated anti-IL-4 (BVD6-24G2) and bioti- 
nylated anti-IFN-y (XMG1.2)  mAbs, respectively. These  anti- 
bodies were purchased from PharMingen. Concentrations of IL-4 
and IFN-y were determined with recombinant IFN-',/ and IL-4 
as standard. 
Results 
IFN-T Production by NK Cells upon Cross-linking of NKR- 
P1.  To  analyze the function of NKR-P1  on mouse NK 
cells, NKI.1 + CD3-  cells were isolated by FACS  |  sorting as 
the NK cell population from spleen (1, 7).  Fig.  1 A  shows 
the  purity  of NK  cells used  in  this  study;  >99%  of the 
sorted cells were NKI.1 + and CD3-.  FACS|  NK 
cells were  expanded  for  3  d  in  the  presence  of IL-2 and 
then  were  harvested  and  analyzed for  IFN-',/ production 
and  proliferative  response  upon  NKR-P1  cross-linking 
with immobilized anti-NKl.1 mAb. The purity of the NK 
cells was  retained during the  3-d culture period (data not 
shown). 
When NK cells were stimulated with immobilized anti- 
NKI.1 mAb in the presence of 1,000 U/ml IL-2, they pro- 
duced a considerable level of IFN-',/(Fig. 2 A), the amount 
being dependent on the concentration of anti-NKl.1 mAb 
used.  Stimulation with  IL-2 alone did not induce produc- 
tion oflFN-3t from NK cells. On the other hand, NK cells 
produced only a small amount of IFN-~/in the absence of 
IL-2.  Production  of IFN-~/  upon  NKR-P1  cross-linking 
was  dependent  on  the  concentration  of IL-2  (Fig.  2  /3). 
Stimulation  of NK  cells  with  immobilized  anti-TCl<-[3 
mAb  (H57.597,  100  Dg/ml)  did not  induce  IFN-~/  pro- 
duction  (data  not  shown).  Furthermore,  the  amount  of 
IFN-y produced upon NKR-P1  cross-linking was as high 
as that produced upon IL-12 stimulation (Fig. 2  C). Similar 
to the stimulation via NKR-P1,  IFN-y production by the 
stimulation with IL-12 was also dependent on the presence 
oflL-2. Only a low level oflFN-~/was produced upon IL-12 
stimulation in the absence of IL-2. On the other hand, the 
presence  of neutralizing  anti-IL-12  mAb  did  not  affect 
IFN-~  production  upon  NKR-P1  cross-linking (Fig.  3), 
indicating that IFN-y production by NK cells upon NKR.- 
P1  cross-linking is not due to the effect oflL-12. These re- 
suits  showed  that  NK_P,-P1  transduces  signals  for  IFN-~ 
production in NK cells in a manner independent oflL-12. 
Regulation of NK Cell Proliferation by NKR-P1.  The  ef- 
fect  of cross-linking of NK1L-P1  on  the  proliferation of 
NK cells was examined next. In the absence of IL-2, cross- 
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Figure 1.  Isolation of NK cells and NKI.1 + T cells. Cells were stained 
for NKI.1  and CD3  and sorted into  NKI.1 + CD3  population (INK 
cells) (A) or NKI.1 + CD3 + population (NKI.1 + T cells) (B). The purity 
of sorted cells was more than 99%. 
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Figure  2.  Production  of IFN-~/ by 
NK cells upon cross-linking  of NKR- 
P1  or IL-12 treatment. (A) NK cells 
were stimulated for 2 d by NKR.-PI 
cross-linking with  anti-NKl.1  mAb 
immobilized at  indicated concentra- 
tions in the presence (open circles) or 
absence (closed circles) of 1,000 U/ml 
IL-2. (B) NK cells were stimulated  by 
NKR-P1  cross-linking  with immobi- 
lized anti-NKl.1 mAb (100 Ixg/ml) at 
graded  concentrations of  IL-2. (C) 
NK cells were stimulated  for 2 d with IL-12 at various concentrations  in the presence (open circles) or absence (closed circles) of 1,000 U/ml IL-2. Repre- 
sentative data from three independent experiments  are shown. 
linking of NKR-P1  as  well  as  IL-12  showed  significant 
[3H]thymidine uptake at  18 h  after stimulation. However, 
when  [3H]thymidine  uptake  was  analyzed  at  48  h  after 
stimulation, only weak [3H]thymidlne uptake was observed 
(Fig. 4 A). Although NK cells proliferated well in the pres- 
ence  of IL-2,  the  [3H]thymidine uptake  was  significantly 
reduced upon NKR-P1 cross-linking (Fig. 4 B).  Inhibition 
of NK cell proliferation by NIZR-P1 cross-linking was also 
observed even with low concentrations of IL-2 (Fig. 4  C), 
suggesting  that  the  reduction  of  [3H]thymidine  uptake 
upon  NKR-P1  cross-hnking was  not  due  to  the  over- 
growth of NK ceils upon stimulation with IL-2 and NKR- 
Pl  cross-linking. Similarly, stimulation of NK  cells  with 
IL-12 also reduced the  [3H]thymidine uptake induced by 
IL-2 (Fig. 4 D). Exogenous IFN-~/showed no effect on the 
proliferative response of NK cells to  the  stimulation with 
IL-2 (data not shown). These results demonstrated that sig- 
nals via NKR-P1  regulate NK cell proliferation, and also 
that NKR-P1 cross-linking exerts a different effect on the 
proliferation of NK cells dependent on the presence oflL-2. 
IFN-T  but  Not  IL-4  Production  by  NK1.1  +  T  Cells  upon 
NKR-P1  Cross-linking.  Next,  to  analyze the  function of 
the  NKR-P1  (NKI.1) molecule expressed on NKI.1 +  T 
cells, we purified NKI.1 + CD3 + T  cells from thymus by cell 
sorting (see Fig. 1 B).  Similar to NK cells, when NKI.1 + T 
cells were stimulated by NKR-P1 cross-linking in the pres- 
ence of IL-2, these  cells produced a significant amount of 
IFN-'y during 3  d  culture (Fig. 5 A). However, these cells 
hardly produced IL-4 upon NKR-P1 cross-linking (Fig. 5 
B).  IL-12 also  induced the  production of IFN-~/ but not 
IL-4 from NKI.1 + T  cells. On the other hand, consistent 
with our previous report (17), when NKI.1 + T  cells were 
Figure 3.  Production  oflFN-y 
by NK cells upon cross-linking 
of NKR-P1  in the presence of 
neutralizing  anti-lL-12  mAb. 
,'-  NK  cells were stimulated with 
immobilized anti-NKl.1  mAb 
(100 Ftg/ml) or IL-12 (100 pg/ml) 
in the presence (open histogram) 
NKI.I  IL-12  or absence (closed histogram) of 50 
p~g/ml anti-IL-12 mAb. We ob- 
served that 0.5 p~g/ml  anti-IL-12 mAb was enough to neutralize 1 ng/ 
ml IL-12. Representative data from three independent experiments  are 
shown, 
stimulated with anti-TC1k-13 mAb, both IL-4 and IFN-~/ 
were  equally produced.  Even when cells were  stimulated 
with low  concentrations of anti-TCR-13 mAb,  IL-4 was 
readily  detected  at  an  equal  level  to  IFN-y  (data  not 
shown).  These  results  demonstrate  that  NKI.1 +  T  cells 
have two functional receptors for IFN-',/production: TCR 
and NKR-P1. 
Discussion 
In the present study, we found that signaling via NKR- 
P1  is  involved  in  IFN-~/  production  by  NK  cells  and 
NK1.1 + T  cells. NKR-P1 cross-hnking induced a high level 
of IFN-y from NK cells compared with that produced by 
IL-12 stimulation. This suggests that signaling via NKR-P1 
is one of the most effective signals for IFN-y production by 
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Figure  4.  Regulation of proliferative response of NK cells by cross- 
linking of NKR.-PI or IL-12. (A) NK cells were stimulated  for indicated 
periods with immobilized anti-NKl.1  mAb (100 p.g/ml) or 5 ng/ml 
IL-12 in the absence of IL-2 and analyzed  for [3H]thymidine  uptake. (B) 
NK cells were stimulated  for 2 d with anti-NKl.1 mAb immobilized  at 
graded concentrations  in the presence (open circles) or absence (closed circles) 
of 1,000 U/ml IL-2. (C) NK cells were cultured at graded concentrations 
of IL-2 in the presence (open circles) or absence (closed circles) of immobi- 
lized anti-NKl.1 mAb (100 ~g/ml). (D) NK cells were stimulated  for 2 d 
with IL-12 at graded concentrations  in the presence (open circles) or ab- 
sence (closed circles) of 1,000 U/ml IL-2. Representative data from three 
independent experiments  are shown. 
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Figure  5.  Production  of 1FN-y by NKI.1 + T  cells upon NKR.-P1 
crossqinking, IL-12 treatment, and TCP, cross-linking. NKI.1 + T cells 
were stimulated with immobilized anti-NKI. 1 mAb (100 I-Lg/ml), anti- 
TCP,-~ mAb (100 t*g/ml), or IL-12 (500 pg/ml) in the presence of IL-2 
(1,000 U/ml) for 3 d, and the amounts of IFN-"/(A) and IL-4 (B) in the 
culture supernatant were analyzed by an ELISA assay. Representative data 
from three independent experiments are shown. 
NK ceils. Recently,  the ligand for NKI<-P1 was identified 
as  certain  kinds  of oligosaccharides.  Recognition  of these 
oligosaccharides  on  target  cells  by NKI<-P1  was  essential 
for induction  of NK  cell  cytotoxicity  (9).  Therefore,  it  is 
likely  that  NK  cells  produce  IFN-y  upon  recognition  of 
such oligosaccharides by the NKR-P1  molecule. Although 
the  distribution  of the  oligosaccharides  as  the  ligand  of 
NKR-P1  is unclear at present,  it is likely that IFN-~/pro- 
duced by NK cells upon stimulation  with  oligosaccharides 
on virus-infected cells or tumor cells regulates the immune 
response  against  these  cells.  Indeed,  IFN-y  produced  by 
NK  ceils  is  involved  in  immune  defense  against  certain 
kinds of pathogens  (10-12). 
Although  NK  cells  produced  significant  amounts  of 
IFN-~/  even  in  the  absence  of IL-2,  exogenous  IL-2 was 
found to significantly increase the production oflFN-~/upon 
NKP,-P1  cross-linking  as well  as  stimulation  with  IL-12. 
Although the exact mechanism of the effect of IL-2 on the 
NKR-Pl-induced  IFN-y production is unclear, one possi- 
ble role of IL-2 in the  production  of IFN-~/ is to prevent 
NK cells from death in vitro, because NK cells die readily 
in vitro in the  absence  of IL-2.  Since  NK and NKI.1 +  T 
cells  constitutively  express  [3  and ~  chains  of the  IL-2 re- 
ceptor, signaling via IL-2R may be involved in the mainte- 
nance of NK cells in vivo. 
Another unique  effect of NKP,-P1  cross-linking on NK 
cells  was  the  regulation  of  the  proliferative  response. 
Whereas  the  signal  via NKR-P1  induced  proliferation  of 
NK cells in the initial phase after stimulation in the absence 
of IL-2, the same stimulus inhibited the IL-2-induced pro- 
liferative response. A  similar effect was observed when NK 
cells were  stimulated  with  IL-12.  Since  exogenous  IFN-~ 
did  not  influence  NK  cell  growth,  the  growth  inhibition 
upon  stimulation  through  NKR-P1  was not  mediated by 
IFN-~/ produced  upon  NKR-P1  cross-linking.  Inhibition 
of IL-2-induced proliferation has also been observed when 
T  cell clones are activated via TCR,  and it is thought to be 
involved  in  the  prevention  of hyperresponsiveness  of T 
cells  (32).  Although  the  physiological  meanings  of  the 
growth inhibition  upon NKR-P1  cross-linking have to be 
determined,  NKR-P1  transduces signals important for reg- 
ulating growth of NK cells. 
We  found  that  not  only  NK  cells  but  also  NKI.1 +  T 
cells produced  IFN-~/upon  cross-linking of NKR-P1.  In- 
terestingly,  whereas  NKI.1 +  T  cells  produced  both  IL-4 
and IFN-y upon TCR  stimulation, stimulation of NKR-P1 
did not induce  IL-4 production from NK1.1 + T  cells. It is 
unlikely that this effect was due to weak signals transduced 
through  NKR-P1  as compared with those  through  TCR, 
because both IL-4 and IFN-y were equally produced upon 
stimulation  with  a  low  concentration  of anti-TCR  mAb 
(data not shown).  These observations suggest an important 
role of NKR-P1  in the differentiation  of Thl/Th2  cells in 
immune response by regulating lymphokine production by 
NKI.1 + T  cells (27,  29,  30).  The different pattern oflym- 
phokine production upon cross-linking of these two differ- 
ent  Ag receptors,  TCR  and  NKR-P1,  suggests  the  exis- 
tence of distinct signaling pathways mediated through these 
two receptors. 
Cross-linking  of NKR-P1  is  known  to  trigger  a  Ca  2+ 
influx and inositol phosphate  metabolism (9, 33).  Further- 
more,  cytoplasmic  domains  of NKR-P1  molecule  have  a 
consensus  motif (Cys-X-Cys-Pro)  involved in the  associa- 
tion  of CD4  and CD8  molecules with the  tyrosine kinase 
p56  kk.  However,  the mechanism  of the  signaling pathway 
via NKR-P1,  including  the  association between NKR-P1 
and p56 lck, has not been investigated. Because the ligand for 
NKR.-P1  was identified  to be certain  oligosaccharides  and 
NKR-P1  triggers  not  only  cytotoxicity  but  also  IFN-~/ 
production by NK cells and NKI.1 + T  cells, the analysis of 
signal  transduction  through  NKR-P1  is  crucial  for  eluci- 
dating the  activation  mechanism  of NK cells and  NK1.1 + 
T  cells. 
Finally,  in the present study, we showed that signals via 
NKR-P1  effectively induced IFN-~/production  both from 
NK cells and NKI.1 + T  cells. IFN-y produced by NK cells 
is known  to play a role in determining Th cell differentia- 
tion  (2,  10). While IL-12 exerts a remarkable effect on the 
induction  of IFN-y  by NK  cells,  IFN-~/  seems to  be  re- 
quired for IL-12 production by macrophage after BCG in- 
fection  (15).  Therefore,  there  is the possibility that IFN-~/ 
production  by NK cells via NKR-P1,  independent  of the 
IL-12  pathway,  may  have  an  important  role  in  immune 
regulation.  The  analysis of the  distribution  of oligosaccha- 
rides,  as  the  ligand  of NKR-P1,  and  the  contribution  of 
NKR-P1  to the  immune  response  will  clarify the  physio- 
logical role of IFN-y production via NKR-P1. 
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Note added in proof: IFN-3' production from NK cells was also observed even when NKR-P1 was cross- 
linked by immobilized (Fab')2 fragment of anti-NKl.1 mAb. This excludes the involvement of Fc receptor 
in the IFN-',/production  observed in this study. 
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